Contact us at

Event Partners

Media Partners


Commercialisation & Market Access Strategies for Orphan & Ultra-Orphan Drugs

Event overview:

Focusing on orphan & ultra orphan drugs, this event will provide a fresh and original perspective on one of the most fascinating fields in market & patient access. Communicating value and cost-effectiveness with payers, regulators and other key stakeholders, in such niche markets, requires innovation & out-of-the box models and strategies.

The event will be unique because unlike other general pricing & reimbursement meetings which are broadly-focused, it will be focused on orphan therapies and will guarantee all participants will access the most relevant case studies & views which directly affects their future business plans and can increase market & patient access.

Why Attend?

  • Get updated with the latest health systems overviews and decision making processes regarding orphan drugs.
  • Learn how innovative & risk-sharing reimbursement models can be implemented in orphan drugs.
  • Find out to what extent orphan treatments are being incentivised, prioritised & in which markets.
  • Find out when to pursue an orphan drug strategy and how.
  • Understand how to overcome challenges in demonstrating niche product value to HTA agencies & payers
  • Appreciate the patient's and physician's perspective to view the complete picture
  • Discuss the effect of off-label use and the challenges it brings to pharma & non-pharma decision makers

Who will benefit?

  • Pharmaceutical companies:
  • Vice-Presidents, Directors, Managers involved in Orphan treatments:
  • Pricing & Reimbursement, Health Economics & Outcomes, Government & Stakeholder Relations,
  • Regulatory Affairs, Medical Affairs, Commercial & Portfolio Strategy, Public Policy, Marketing, Therapy Area Heads, Market Access, Country Managers
  • Solution providers & consultants:
  • CEOs, Business Development, Senior Consultants, Regional Heads
  • Independent Academics, Health Economists, Senior Doctors, & Patient Representatives.

Your Prestigious Speaker Panel

A more detailed list of speakers’ names is available on the downloadable agenda. Please "request event agenda" below.

Industry Experts

Senior Vice President, Public Policy
Genzyme Corporation, Belgium
Chairman
joint EBE/Europabio European industry Task Force on Rare Diseases and Orphan Drugs

Associate Director, Market Access
Health Policy and Market Access
Merck Serono SA, Switzerland

Director of Scientific and Medical Affairs
LFB, France

Senior Manager EU Market Access
Celgene Europe, UK

Director, Market Access and Public Affairs, EMEA
Shire Human Genetic Therapies, France

Payers

SVP, Head of Product Management
D A K (leading German statutory health insurance)

Leading Opinion Figures

Senior Consultant, Department of Pharmacology,
University Hospital of Bordeaux
Former Head of the Clinical Trials Unit,
The French Medicines Agency (AFSSAPS)
Former Scientific Administrator,
EMEA
Former Medical Advisor,
The French National Health Fund

Senior Economist
Office of Health Economics (OHE), UK

Prof. of Market Access
University Of Lyon, France

Patient Groups

Senior Representative
The Macular Disease Society, UK

Director
Oncology Center Antwerp
Secretary
Europa Uomo
Chairman
PAC committee ECCO, Belgium

Experienced Market-Access Solution Providers

Senior Research Consultant
Pharmerit International

Business Development Director
Creativ-Ceutical, France

 
Home | Corporate Profile | Intelligent Events
Partnering Opportunities | Client Testimonials | Recruitment | Contact
Copyright 2007-2010 @ All rights reserved
b2bsolutions.sk